{"id":"placebo-of-hydroxyzine","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL3186993","moleculeType":"Small molecule","molecularWeight":"447.83"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"A placebo of hydroxyzine is an inert formulation used as a control in clinical trials to compare against the active hydroxyzine drug. It allows researchers to isolate the true therapeutic effect of hydroxyzine from placebo response. The placebo itself has no mechanism of action.","oneSentence":"This is a placebo control arm and contains no active pharmaceutical ingredient; it produces no pharmacological effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:51:33.108Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in phase 3 clinical trial of hydroxyzine"}]},"trialDetails":[{"nctId":"NCT02604199","phase":"PHASE2","title":"A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic Hepatitis B Virus (HBV) Infection","status":"TERMINATED","sponsor":"Arrowhead Pharmaceuticals","startDate":"2015-09","conditions":"Hepatitis B","enrollment":58},{"nctId":"NCT02604212","phase":"PHASE2","title":"A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic Hepatitis B Virus Infection","status":"TERMINATED","sponsor":"Arrowhead Pharmaceuticals","startDate":"2015-11","conditions":"Hepatitis B","enrollment":32},{"nctId":"NCT02797522","phase":"PHASE1","title":"A Study of ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB)","status":"TERMINATED","sponsor":"Arrowhead Pharmaceuticals","startDate":"2016-06","conditions":"Hepatitis B","enrollment":47},{"nctId":"NCT03808805","phase":"PHASE3","title":"Aprepitant Versus Hydroxyzine in Persistent Aquagenic Pruritus for Patients With Myeloproliferative Neoplasms","status":"COMPLETED","sponsor":"University Hospital, Brest","startDate":"2019-04-16","conditions":"Myeloproliferative Disorder, Aquagenic Pruritus","enrollment":63},{"nctId":"NCT05946551","phase":"PHASE3","title":"Treatment of Long CoronaVirus Disease (COVID) (TLC) Feasibility Trial","status":"TERMINATED","sponsor":"Emory University","startDate":"2024-03-08","conditions":"COVID-19","enrollment":5},{"nctId":"NCT06754410","phase":"PHASE3","title":"Efficacy of Antihistamine Drugs as Medical Expulsive Therapy Alone or in Combination With Alpha Blockers: A Prospective Randomized Controlled Study","status":"COMPLETED","sponsor":"South Valley University","startDate":"2021-03-01","conditions":"Lower Ureteric Stones","enrollment":480},{"nctId":"NCT00751218","phase":"PHASE4","title":"A Comparative Double-Blind, Double- Dummy Study of Desloratadine (DL) 5 MG Once Daily, Cetirizine 10 MG Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03735)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-05-06","conditions":"Urticaria","enrollment":174},{"nctId":"NCT00751166","phase":"PHASE4","title":"A Comparative Double-blind, Double-dummy Study of Desloratadine (DL) 5 mg Once Daily, Cetirizine 10 mg Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03736)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2004-03-01","conditions":"Urticaria","enrollment":149},{"nctId":"NCT04990388","phase":"PHASE1, PHASE2","title":"Safety, Tolerability, and Pharmacokinetics of UX053 in Patients With Glycogen Storage Disease Type III (GSD III)","status":"TERMINATED","sponsor":"Ultragenyx Pharmaceutical Inc","startDate":"2021-10-18","conditions":"Glycogen Storage Disease Type III","enrollment":9},{"nctId":"NCT05095311","phase":"PHASE4","title":"The Effect of Cetirizine HCl on Exercise-induced Arterial Hypoxemia in Highly-trained Swimmers","status":"TERMINATED","sponsor":"Indiana University","startDate":"2021-05-19","conditions":"Exercise-induced Arterial Hypoxemia","enrollment":16},{"nctId":"NCT05680584","phase":"PHASE1","title":"Comparison Between Oral Melatonin and Hydroxyzine in Pediatric Patients Undergoing Adenotonsillectomy","status":"UNKNOWN","sponsor":"Minia University","startDate":"2023-02-01","conditions":"Effect of Drug, Anxiety","enrollment":78},{"nctId":"NCT03453632","phase":"PHASE2, PHASE3","title":"Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa Simplex","status":"UNKNOWN","sponsor":"University Hospital, Toulouse","startDate":"2018-06-14","conditions":"Epidermolysis Bullosa Simplex","enrollment":25},{"nctId":"NCT04481412","phase":"PHASE2, PHASE3","title":"Topical Cetirizine in Androgenetic Alopecia in Females","status":"COMPLETED","sponsor":"Cairo University","startDate":"2020-07-25","conditions":"Androgenetic Alopecia","enrollment":66},{"nctId":"NCT03158376","phase":"PHASE3","title":"Preoperative Gabapentin for Chronic Pain After Thoracotomy (GABATHOMIE).","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2015-09","conditions":"Postoperative Pain, Chronic Pain","enrollment":201},{"nctId":"NCT03340740","phase":"PHASE4","title":"The Effect of Cetirizine on Bronchoconstriction","status":"COMPLETED","sponsor":"New York City Health and Hospitals Corporation","startDate":"2018-05-11","conditions":"Allergic Rhinitis, Asthma","enrollment":40},{"nctId":"NCT04836806","phase":"PHASE4","title":"Cetirizine and Famotidine for COVID-19","status":"WITHDRAWN","sponsor":"Emory University","startDate":"2021-08","conditions":"Covid19","enrollment":""},{"nctId":"NCT01971853","phase":"NA","title":"Does Preventive Analgesia Improve the Outcome of Demerol-Vistaril Procedural Sedations in Pediatric Dentistry","status":"TERMINATED","sponsor":"University of Colorado, Denver","startDate":"2013-10","conditions":"Pain","enrollment":88},{"nctId":"NCT04237090","phase":"PHASE3","title":"Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel","status":"COMPLETED","sponsor":"Ciusss de L'Est de l'Île de Montréal","startDate":"2020-02-14","conditions":"Breast Cancer, Lung Cancer, Ovarian Cancer","enrollment":27},{"nctId":"NCT03192488","phase":"PHASE4","title":"Effect of an H1 Receptor Antagonist on Exercise Performance in Hypoxia","status":"COMPLETED","sponsor":"Indiana University","startDate":"2017-08-31","conditions":"Hypoxia, Altitude","enrollment":13},{"nctId":"NCT04293822","phase":"PHASE4","title":"Topical Cetirizine 1% vs Minoxidil 5% Gel in Treatment of Androgenetic Alopecia","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2020-06","conditions":"Androgenetic Alopecia","enrollment":60},{"nctId":"NCT04184141","phase":"PHASE4","title":"Preoperative Use of Alprazolam and Hydroxyzine in Anxiety","status":"UNKNOWN","sponsor":"Istanbul Medeniyet University","startDate":"2019-12-01","conditions":"Agitation on Recovery From Sedation","enrollment":90},{"nctId":"NCT01241214","phase":"PHASE2","title":"Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2010-11","conditions":"Seasonal Allergic Rhinitis","enrollment":579},{"nctId":"NCT02543346","phase":"PHASE4","title":"Comparability and Standardization of Controlled Allergen Challenge Facilities","status":"COMPLETED","sponsor":"Queen's University","startDate":"2015-10","conditions":"Allergic Rhinitis","enrollment":98},{"nctId":"NCT01825655","phase":"PHASE4","title":"Study of Using Long Acting Antihistamine to Treat Opioid Induced Itching","status":"TERMINATED","sponsor":"Virginia Commonwealth University","startDate":"2014-09","conditions":"Pruritus","enrollment":3},{"nctId":"NCT01484119","phase":"PHASE3","title":"Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2011-12","conditions":"Seasonal Allergic Rhinitis","enrollment":630},{"nctId":"NCT00291642","phase":"PHASE2","title":"A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2006-01-01","conditions":"Rhinitis, Allergic, Seasonal","enrollment":551},{"nctId":"NCT01916226","phase":"PHASE4","title":"A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-08-01","conditions":"Rhinitis, Allergic, Perennial and Seasonal","enrollment":682},{"nctId":"NCT00490204","phase":"PHASE3","title":"Cetirizine Placebo Controlled Study For Perennial Allergic Rhinitis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-07-27","conditions":"Rhinitis, Allergic, Perennial","enrollment":239},{"nctId":"NCT02447393","phase":"PHASE1","title":"Phase 1 Study of Levocetirizine","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-03-18","conditions":"Dermatitis","enrollment":20},{"nctId":"NCT00972504","phase":"PHASE2","title":"723/726 Proof of Concept Study in Allergen Challenge Chamber in Hannover","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-06-01","conditions":"Rhinitis, Allergic, Seasonal","enrollment":54},{"nctId":"NCT00661674","phase":"NA","title":"Palonosetron and Hydroxyzine to Reduce Opioid Withdrawal","status":"COMPLETED","sponsor":"Stanford University","startDate":"2008-04","conditions":"Substance-Related Disorders","enrollment":10},{"nctId":"NCT02932774","phase":"PHASE4","title":"Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","sponsor":"Johnson & Johnson Consumer and Personal Products Worldwide","startDate":"2001-03","conditions":"Allergic Rhinitis, Hay Fever, SAR","enrollment":683},{"nctId":"NCT01557712","phase":"PHASE3","title":"Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks","status":"COMPLETED","sponsor":"University Hospital, Grenoble","startDate":"2012-03","conditions":"Major Depressive Disorder","enrollment":25},{"nctId":"NCT01103050","phase":"PHASE2","title":"A Cross Over Study to Compare the Effect of Combined Treatment With QAV680 and Cetirizine","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2010-03-22","conditions":"Allergic Rhinitis","enrollment":60},{"nctId":"NCT00851344","phase":"PHASE2","title":"Allergen Challenge Chamber Study With Single Dose Oral GSK835726 Compared With Placebo","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-09","conditions":"Rhinitis, Allergic, Seasonal","enrollment":54},{"nctId":"NCT01675986","phase":"PHASE2","title":"Comparing the Efficacy of Pregabalin and Hydroxyzine on the Anxiety Score","status":"COMPLETED","sponsor":"Poitiers University Hospital","startDate":"","conditions":"Feeling Anxious","enrollment":306},{"nctId":"NCT00260481","phase":"PHASE2, PHASE3","title":"Prometa Pharmacotherapy for Methamphetamine Dependence","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2006-01","conditions":"Drug Abuse, Drug Dependence","enrollment":120},{"nctId":"NCT01985789","phase":"PHASE4","title":"Anti-histamines and Methacholine Challenges.","status":"COMPLETED","sponsor":"Don Cockcroft","startDate":"2013-11","conditions":"Asthma","enrollment":12},{"nctId":"NCT01151696","phase":"PHASE4","title":"Pain and Anxiety Management of Traumatic Emergency in a Pre-hospital Setting","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2010-05","conditions":"Pain","enrollment":140},{"nctId":"NCT01981499","phase":"PHASE1","title":"A Study of the Safety, Tolerability, Pharmacokinetics, And Effects On Histamine-Induced Wheal Of PF-05180999 In Healthy Adults","status":"TERMINATED","sponsor":"Pfizer","startDate":"2014-01","conditions":"Migraine","enrollment":31},{"nctId":"NCT01748344","phase":"PHASE2","title":"Phase II Study Evaluating ONO-4053 and Cetirizine in Subjects With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Ono Pharmaceutical Co. Ltd","startDate":"2012-11","conditions":"Seasonal Allergic Rhinitis","enrollment":58},{"nctId":"NCT01318681","phase":"NA","title":"Rhinitis, Cognition and Driving Performance","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2011-01","conditions":"Seasonal Allergic Rhinitis, Driving Ability, Cognition","enrollment":22},{"nctId":"NCT01496911","phase":"PHASE4","title":"Effects of Levocetirizine and Hydroxyzine on Cognitive and Psychomotor Functioning During Simulated Diving","status":"COMPLETED","sponsor":"Utrecht Institute for Pharmaceutical Sciences","startDate":"2012-04","conditions":"Healthy Volunteers","enrollment":24},{"nctId":"NCT01781507","phase":"PHASE4","title":"Study of Bronchodilation Effects of Cetirizine","status":"COMPLETED","sponsor":"California Allergy and Asthma Medical Group, Inc.","startDate":"2011-06","conditions":"Allergic Rhinitis, Asthma","enrollment":21},{"nctId":"NCT00561717","phase":"PHASE4","title":"A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-10","conditions":"Seasonal Allergic Rhinitis","enrollment":70},{"nctId":"NCT00488176","phase":"PHASE4","title":"Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic Rhinitis","status":"UNKNOWN","sponsor":"Medical University of Lodz","startDate":"2007-04","conditions":"Seasonal Allergic Rhinitis","enrollment":116},{"nctId":"NCT01127620","phase":"PHASE3","title":"Efficacy Study for the Symptomatic Treatment of Perennial Allergic Rhinitis With a 1 Year Safety Extension","status":"COMPLETED","sponsor":"Faes Farma, S.A.","startDate":"2004-05","conditions":"Perennial Allergic Rhinitis","enrollment":650},{"nctId":"NCT00420082","phase":"PHASE2","title":"A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of Bilastine in the Vienna Challenge Chamber","status":"COMPLETED","sponsor":"Faes Farma, S.A.","startDate":"2006-10","conditions":"Seasonal Allergic Rhinitis","enrollment":75},{"nctId":"NCT00504933","phase":"PHASE3","title":"Efficacy Study for the Symptomatic Treatment of Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Faes Farma, S.A.","startDate":"2005-05","conditions":"Seasonal Allergic Rhinitis","enrollment":683},{"nctId":"NCT00375713","phase":"PHASE3","title":"Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizine) in Subjects With Dermatitis and Eczema","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2005-10","conditions":"Dermatitis, Eczema","enrollment":466},{"nctId":"NCT00240032","phase":"PHASE4","title":"A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2004-10","conditions":"Multiple Sclerosis","enrollment":80},{"nctId":"NCT01055236","phase":"PHASE4","title":"Hydroxyzine for the Prevention of Pruritus From Spinal Morphine in Transabdominal Hysterectomy Patients","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2007-08","conditions":"Pruritus, Nausea, Vomiting","enrollment":80},{"nctId":"NCT00334698","phase":"NA","title":"Study to Assess the Effect of a Combination of Cetirizine With Pseudoephedrine Versus Cetirizine Alone on Symptoms in Patients With Allergic Rhinitis","status":"COMPLETED","sponsor":"Fraunhofer-Institute of Toxicology and Experimental Medicine","startDate":"2006-07","conditions":"Seasonal Allergic Rhinitis","enrollment":51},{"nctId":"NCT00533637","phase":"PHASE2","title":"Taste and Local Tolerance Study of NLA Nasal Spray in Patients With Allergic Rhinitis","status":"COMPLETED","sponsor":"Biolipox AB","startDate":"2007-09","conditions":"Allergic Rhinitis","enrollment":28},{"nctId":"NCT00162786","phase":"PHASE4","title":"Comparative Effects of Rupatadine 10 mg, Hydroxyzine 50 mg and Placebo on Actual Driving Performance","status":"TERMINATED","sponsor":"J. Uriach and Company","startDate":"2005-05","conditions":"Healthy","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo of Hydroxyzine","genericName":"Placebo of Hydroxyzine","companyName":"University Hospital, Brest","companyId":"university-hospital-brest","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a placebo control arm and contains no active pharmaceutical ingredient; it produces no pharmacological effect. Used for Control arm in phase 3 clinical trial of hydroxyzine.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}